Foghorn Therapeutics (FHTX) Shares Outstanding (2019 - 2026)

Foghorn Therapeutics' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $58.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 5.36% year-over-year to $58.7 million; the TTM figure through Mar 2026 stood at $58.7 million (up 5.36% YoY), while the FY2025 annual figure was $56.7 million, up 1.91% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $58.7 million, up from $56.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $58.7 million in Q1 2026, with the low at $41.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $42.6 million (2024), against an average of $48.7 million.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) increased 0.54% in 2023, then surged 32.2% in 2024.
• Foghorn Therapeutics' Shares Outstanding (Entity) stood at $41.8 million in 2022, then advanced by 1.14% to $42.3 million in 2023, then soared by 31.48% to $55.6 million in 2024, then rose by 1.91% to $56.7 million in 2025, then increased by 3.62% to $58.7 million in 2026.
• Business Quant data shows FHTX's Shares Outstanding (Entity) at $58.7 million in Q1 2026, $56.7 million in Q4 2025, and $56.5 million in Q3 2025.